Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Gut|July 20, 2024
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis BAndrea Vecchi, Marzia Rossi, Camilla Tiezzi, et al.
Journal of Hepatology|August 22, 2019
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failureElisabetta Degasperi, Angiola Spinetti, Andrea Lombardi, et al.
Hepatology (Baltimore, Md.)|March 16, 2021
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off ApproachLaura Cristoferi, Vincenza Calvaruso, Diletta Overi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 1, 2025
Clinical Features, Management and Prognosis of Hepatic Sarcoidosis: Insights From a Nationwide Italian StudyCristina Della Corte, Daphne D'Amato, Adele Rocchetti, et al.
Hepatology Communications|November 23, 2021
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort StudyLuca Valenti, Serena Pelusi, Alessio Aghemo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 14, 2024
Noninvasive Assessment of portal Hypertension in Patients With Primary Biliary Cholangitis is Affected by Severity of CholestasisVincenza Calvaruso, Ciro Celsa, Laura Cristoferi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 4, 2025
Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real-World DatabaseAlessandro Loglio, Ivan Gardini, Massimiliano Conforti, et al.
Gut|March 20, 2021
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysisVictor Sapena, Marco Enea, Ferran Torres, et al.
Journal of Hepatology|January 10, 2025
Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosisElisabetta Degasperi, Maria Paola Anolli, Mathias Jachs, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 27, 2024
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohortLoreta A Kondili, Giuseppina Brancaccio, Maria Elena Tosti, et al.
Pageof 9